U-M human embryonic stem cell line placed on national registry
The University of Michigan’s first human embryonic stem cell line will be placed on the U.S. National Institutes of Health’s registry, making the cells available for federally-funded research. It is the first of the stem cell lines derived at the University of Michigan to be placed on the registry.
A stem cell line is a family of constantly dividing cells, the product of a single group of stem cells. The cells can replicate for long periods of time in a research lab.
“This is significant, because acceptance of these cells on the registry demonstrates our attention to details of proper oversight, consenting, and following of NIH guidelines established in 2009,” says Gary Smith, Ph.D., who derived the line and also is co-director of the U-M Consortium for Stem Cell Therapies, part of the A. Alfred Taubman Medical Research Institute.
“It now makes the line available to researchers who can apply for federal funding to use it in their work; this is an important step.”
Researchers envision a future where “normal” stem cell lines and disease-specific stem cell lines can be used together to discover treatments and cures for genetic diseases.
Read the full press release.










